Cover Image

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients

Saved in:

Bibliographic Details
Main Authors:	Sandra Hasmann (Author), Michael Paal (Author), Louise Füeßl (Author), Michael Fischereder (Author), Ulf Schönermarck (Author)
Format:	Book
Published:	Elsevier, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2 vaccination in haemodialysis patients: Insides from a prospective study comparing mRNA and viral vector vaccines
by: Louise Füessl, et al.
Published: (2022)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients-Authors´ Reply
by: Julian Stumpf, et al.
Published: (2021)

Humoral immunity for durable control of SARS-CoV-2 and its variants
by: Ryutaro Kotaki, et al.
Published: (2023)

Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients
by: Susan Trümpelmann, et al.
Published: (2022)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
by: Zhao WM, et al.
Published: (2022)

Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection
by: Julia Schiffner, et al.
Published: (2021)

Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
by: Clara Udaondo, et al.
Published: (2022)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
by: Maria Gonzalez-Perez, et al.
Published: (2023)

Humoral immune response to SARS-CoV-2 in pregnant and nonpregnant women following infectionAJOG Global Reports at a Glance
by: Marni B. Jacobs, PhD, et al.
Published: (2023)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
by: Michael Levin, et al.
Published: (2022)

Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice
by: Smital Patil, et al.
Published: (2023)

Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines
by: Fayhan Alroqi, et al.
Published: (2024)

Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity
by: Marija Vukčević, et al.
Published: (2024)

Update on SARS-CoV-2: Pathogenesis, Immunity, Treatment Protocol and Vaccines in Perspective
by: K M Vidya
Published: (2020)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
by: Diego A. Díaz-Dinamarca, et al.
Published: (2023)

Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review
by: Silvia Martinelli, et al.
Published: (2023)

Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies
by: Linda Elise Couëssurel Wüsthoff, et al.
Published: (2024)

Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection
by: Matteo Franchi, et al.
Published: (2023)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
by: Kit Man Chai, et al.
Published: (2021)

Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023)

T cells in SARS-CoV-2 infection and vaccination
by: Arthur Young
Published: (2022)

Role of innate immunity in SARS-CoV-2 infection
by: Zihao Wang, et al.
Published: (2023)

An update on SARS-CoV-2 immunization and future directions
by: Rashmi Rana, et al.
Published: (2023)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

Innate immune recognition against SARS-CoV-2
by: Taisho Yamada, et al.
Published: (2023)

Immune Dysregulation in Acute SARS-CoV-2 Infection
by: Lauren Grimm, et al.
Published: (2023)

Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
by: Michael A. Weintraub MD, et al.
Published: (2021)

Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis
by: Tingting Li, et al.
Published: (2022)

Vaccine safety - is the SARS-CoV-2 vaccine any different?
by: Noam Tau, et al.
Published: (2021)

The DiaCoVAb study in South Italy: immune response to Sars-CoV-2 vaccination in dialysis patients
by: Alessandra Fucci, et al.
Published: (2022)

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
by: Isaac Yeboah Addo, et al.
Published: (2022)

Correction: DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
by: Kit Man Chai, et al.
Published: (2023)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
by: Anita M. Shete, et al.
Published: (2022)

A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology
by: Edward J. Quinlan, et al.
Published: (2022)

A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
by: Natia Murvelashvili MD, et al.
Published: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
by: Theodore Pak, et al.
Published: (2023)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023)

Vitiligo Repigmentation After SARS-CoV-2 Vaccine
by: Roberto Bustos-Macaya, et al.
Published: (2023)